ALZ.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$31M	-16.4%	$-0.27	$-0.27–$-0.27	—	1
2027	$11M	-64.9%	$-0.38	$-0.38–$-0.38	—	1
2028	$9M	-15.9%	$-0.38	$-0.38–$-0.38	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
ALZ.STAlzinova AB (publ)	$0.46	-1.18%	$47M	—
ACUC.STAcuCort AB	$0.53	-2.91%	$125M	—
ANNX.STAnnexin Pharmaceuticals AB	$12.70	-0.78%	$91M	—
BRAIN.STBrainCool AB (publ)	$0.92	+3.38%	$362M	—
CMOTEC-B.STScandinavian ChemoTech AB (publ)	$3.67	+0.00%	$87M	—
ISOFOL.STIsofol Medical AB (publ)	$0.73	-0.54%	$236M	—
KLAR.STKlaria Pharma Holding AB (publ.)	$0.59	-3.11%	$145M	—

Source: Financial Modeling Prep · peers by sector/industry

Alzinova AB (publ)

Alzinova AB (publ) is a Swedish biotechnology company dedicated to advancing novel immunotherapies against Alzheimer's disease. Their primary investigational product, ALZ-101, is a vaccine specifically designed to target oligomers responsible for Alzheimer's. Additionally, they are developing ALZ-201, a monoclonal antibody aimed at neutralizing harmful amyloid-beta (Aß) oligomers. Established in 2011, the company's operations are headquartered in Mölndal, Sweden.

www.alzinova.com

Employees: 7
IPO / List date: Nov 25, 2015
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds ALZ.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in ALZ.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded ALZ.ST yet.